Bourillon, L., Bourgier, C., Gaborit, N., Garambois, V., Llès, E., Zampieri, A., . . . Chardès, T. (2019). An auristatin‐based antibody‐drug conjugate targeting HER3 enhances the radiation response in pancreatic cancer. International journal of cancer, 145(7), 1838-1851. https://doi.org/10.1002/ijc.32273
Citace podle Chicago (17th ed.)Bourillon, Laura, et al. "An Auristatin‐based Antibody‐drug Conjugate Targeting HER3 Enhances the Radiation Response in Pancreatic Cancer." International Journal of Cancer 145, no. 7 (2019): 1838-1851. https://doi.org/10.1002/ijc.32273.
Citace podle MLA (9th ed.)Bourillon, Laura, et al. "An Auristatin‐based Antibody‐drug Conjugate Targeting HER3 Enhances the Radiation Response in Pancreatic Cancer." International Journal of Cancer, vol. 145, no. 7, 2019, pp. 1838-1851, https://doi.org/10.1002/ijc.32273.